The marketing authorisation for this product is currently in the process of being transferred to Atnahs from AstraZeneca. Until the transfer is complete the relevant materials below reflect the information supplied by the originator company.
Whilst the Patient Information Leaflets (PIL) are intended to be helpful, they are not intended to replace the advice of a healthcare professional. If you experience any side effects you should immediately seek the advice of a healthcare professional.
Where our products are registered and available in the UK or ROI the Patient Information Leaflets included are those of the UK or ROI, where not registered an alternate is supplied from a registered market. If you would like those for any other countries, please contact firstname.lastname@example.org.